Currently Viewing:
American Diabetes Association 2020 Virtual Scientific Sessions
Currently Reading
Dr Robert Gabbay Discusses New ADA Role; Virtual Scientific Sessions
June 11, 2020
Can a Digital Health Intervention Increase Heart-Healthy Behaviors in Youth With Type 1 Diabetes?
June 13, 2020
Cardiovascular Benefits of Vascepa Greater for Those With Diabetes, New REDUCE-IT Data Show
June 13, 2020
Session Details Interrelations of Youth Obesity, Type 2 Diabetes
June 13, 2020
Racial Disparities Persist in Maternal Morbidity, Mortality and Infant Health
June 13, 2020
Dr Robert Gabbay Reflects on Insulin Cost Caps for Some Medicare Beneficiaries
June 14, 2020
Is Prevention the Future of SGLT2s? Inzucchi Offers Data That Suggest "Yes"
June 14, 2020
COVID-19 Is Changing the A1C vs Time-in-Range Debate, Expert Says
June 15, 2020
Starting Insulin, GLP-1 at Same Time Brings Better Glycemic Control, Real-World Data Show
June 15, 2020
Dr Darren K. McGuire Discusses Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists in T2D
June 16, 2020
Technology Roundup: CGM Systems, Joslin Home Featured at 2020 ADA Scientific Sessions
June 16, 2020
VERTIS CV: Ertugliflozin Falls Short of SGLT2s on CV Outcomes, Despite Promise in Heart Failure
June 16, 2020
Are Newer Diabetes Drug Classes Ready for Prime Time in CV Prevention?
June 16, 2020
DPP Continues to Yield Positive Results, New DPPOS Data Show
June 17, 2020
Dr Tara Kaushal Discusses Benefits of Active Technology Use as a Health Intervention for T1D
June 26, 2020
Dr Robert Gabbay on Diabetes in the COVID-19 Era
June 30, 2020

Dr Robert Gabbay Discusses New ADA Role; Virtual Scientific Sessions

One advantage of conducting an online scientific conference is that more individuals will gain access to information presented at the meeting, said Robert Gabbay, MD, PhD, the newly appointed chief medical and scientific officer of the American Diabetes Association.


One advantage of conducting an online scientific conference is that more individuals will gain access to information presented at the meeting, said Robert Gabbay, MD, PhD, the newly appointed chief medical and scientific officer of the American Diabetes Association.

Transcript:

As the new chief scientific and medical officer at the American Diabetes Association (ADA), what are your goals for the organization? 

It is the most comprehensive organization focused on improving the lives of people with diabetes and serving the professional community around diabetes. I look to continue to foster that wonderful work and really ensure that it has greater impact on all of our constituents.

This is the 80th Scientific Sessions hosted by the ADA, but the first one to be conducted virtually. What are you looking forward to? 

I think it's an exciting time. Obviously, we've been challenged by coronavirus disease 2019 (COVID-19) to have to pivot to do this virtually. But what we hope is one of the advantages of doing it virtually, is that we can have more people have access to the amazing information that occurs at this meeting. Some years people can't travel to whatever the location is. Now, we can all do this from the comfort of our office or home. I hope that we have even greater participation as a result. Because we are capturing all of the sessions on video, we have the opportunity then to have this as enduring material that can be distributed again, all over the world.

 
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up